ADVISORY: |
The Supreme Court E-Library will undergo a system
maintenance on March 28-31, 2024 and will be inaccessible during this period. Thank you for your understanding! |
CONTACT: |
Supreme Court of the Philippines Library Services, Padre Faura, Ermita, Manila, Philippines 1000 |
(632) 8524-2706 |
libraryservices.sc@judiciary.gov.ph |
(NAR) VOL. 1 NO.2 / APRIL - JUNE 1990
[ DDB BOARD REGULATION NO. 17, s. 1973, November 27, 1973 ]
EXCLUSION OF PERPHYLLON FROM THE LIST OF REGULATED DRUGS
Pursuant to the powers vested in the Dangerous Drugs Board under
Section 36(a) of Republic Act No. 6425, as amended, the pharmaceutical
preparations hereunder described are hereby excluded from the list of
regulated drugs:
Perphyllon
|
Ampules |
Suppositories |
Suppositories |
Tablet |
Oxythylthcophylline |
85 mg |
91 mg |
17 mg |
154 mg |
Pheophylline |
25 mg |
57 mg |
5 mg |
46 mg |
Papaverine Hcl |
30 mg |
80 mg |
20 mg |
50 mg |
8-methl-3tro-poyloxytropanium Hcl |
0.1 mg |
0.3 mg |
0.15 mg |
0.15 mg |
Phenyl-barbituric acid |
|
40 mg |
20 mg |
15 mg |
The exclusion notwithstanding, the above preparations remain prescription items subject to the prescription requirements of R.A. 3720, otherwise known as the Food, Drug, and Cosmetic Act.
This Regulation shall take effect immediately.
Adopted: 27 Nov. 1973
(SGD.) CLEMENTE S. GATMAITAN, M.D., M.P.H.
Chairman